AUA 2017 Bladder Cancer

REVIEW UroToday

Viewing 1-20 of 73 articles

AUA 2017: Trends in surgical approach and outcomes for radical cystectomy: a contemporary population-based analysis

AUA 2017: Impact of prostate involvement on outcomes in patients treated with radical cystoprostatectomy for bladder cancer

AUA 2017: Bladder cancers are not all the same: de novo muscle invasive disease has improved survival compared to invasive disease progressing after intravesical therapy

AUA 2017: Comparison of total 90 day costs for open versus robotic cystectomy

AUA 2017: Venous thromboembolism rates following radical cystectomy stratified by method of prophylaxis

AUA 2017: Restrictive transfusion in radical cystectomy is safe

AUA 2017: The prognostic value of postoperative clinical and laboratory parameters regarding the oncological outcome of patients undergoing radical cystectomy for urothelial cell carcinoma of the bladder

AUA 2017: Does sarcopenia impact oncologic outcomes in patients undergoing adjuvant chemotherapy following radical cystectomy?

AUA 2017: Late-Breaking Abstract – Interim results from a single-arm multicenter Phase II trial of CG0070, an oncolytic adenovirus, for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC)

AUA 2017: Late-Breaking Abstract – Targeting epidermal growth factor receptor (EGFR) and human epidermal growth factor 2 expressing bladder cancer using combination photoimmunotherapy (PIT)

AUA 2017: Late-Breaking abstract- A phase III blinded study of immediate post-TURBT instillation of gemcitabine versus saline in patients with newly diagnosed or occasionally recurring Grade I/II non-muscle invasive bladder cancer: SWOG S0337

AUA 2017: A prospective study on the impact of radical cystectomy on sexual function in females with bladder cancer

AUA 2017: National surgical quality improvement program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversion: the case for a procedure-specific risk calculator

AUA 2017: Centralization of Radical Cystectomy for Bladder Cancer in a Universal Healthcare System: Early Results from a Canadian Academic Center

AUA 2017: Late-Breaking Abstract- Blue Light Flexible Cystoscopy (BLFC) with Hexaminolevulinate (HAL) and White Light Flexible cystoscopy: A Prospective, Comparative, Within-Patient controlled Multi-Center Phase 3 Study in the Detection of Bladder Cancer

AUA 2017: A Comparison of Post-Cystectomy Recurrence and Survival in NAC-Responsive MIBC vs. High-Risk NMIBC Patients

AUA 2017: Validation of VTE Score in Major Urologic Cancer Surgery

AUA 2017: Is compliance to an enhanced recovery protocol after radical cystectomy associated with improved post operative outcomes?

AUA 2017: A Comparison of Post-cystectomy Recurrence and Survival in NAC-responsive MIBC vs. High-risk NMIBC Patients: Similar Pathologic Stage Yet Different Outcomes

AUA 2017: Cross-sectional Study Evaluating Long-term Bowel Issues in Bladder Cancer Patients: Diarrhea as a Limiting Factor of Quality of Life After Radical Cystectomy

1
2
3
4